A rating of 70 puts Evolus Inc (EOLS) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Evolus Inc's score of 70 means it scores higher than 70% of stocks in the industry. Evolus Inc also received an overall rating of 40, putting it above 40% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 134 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Evolus Inc Stock Today?
Evolus Inc (EOLS) stock has fallen -0.78% while the S&P 500 is up 1.24% as of 11:42 AM on Monday, Sep 28. EOLS has fallen -$0.03 from the previous closing price of $3.86 on volume of 143,466 shares. Over the past year the S&P 500 is higher by 12.18% while EOLS has fallen -75.48%. EOLS lost -$2.67 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Evolus Inc (EOLS) Stock.